Katherine Moggridge

Katherine Moggridge

Key Details

Katherine Moggridge
Barrister
Three New Square
UK

Overview

Called to the bar in 2012, Katherine Moggridge is now a tenant at Three New Square. She has worked on high-profile cases for clients including Eli Lilly, Samsung Bioepis/Biogen, Apple and Juul. Moggridge was the sole junior on the appeal, which settled before judgment was handed down, in Fujifilm Kyowa Kirin Biologics Company v Abbvie Biotechnology. The net result of the AbbVie litigation was that biosimilars to the global blockbuster Humira were able to launch in the UK, which is set to save the NHS £300 million ($391 million). Moggridge is part of Three New Square’s interview panel for pupillage and runs the mini-pupillage committee. She is actively involved in a number of groups aimed at focussing on the progression of women in IP, including ‘Lean In’ groups and the London chapter of ChIPs. Moggridge is the first female member to have a baby in the chambers’ history, and she instigated a rewrite of the chamber’s maternity leave. In addition, Moggridge is the first female author of “Terrell on the Law of Patents”.

WIPR